Spots Global Cancer Trial Database for tenosynovial giant cell tumor

Every month we try and update this database with for tenosynovial giant cell tumor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients	NCT04938180	Tenosynovial Gi... Pigmented Villo... TGCT PVNS - Pigmente...	AMB-05X	18 Years -	AmMax Bio, Inc.
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor	NCT04192344	Neoplasms Tenosynovial Gi...	ABSK021	18 Years -	Abbisko Therapeutics Co, Ltd
Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor	NCT02471716	Pigmented Villo... Tenosynovial Gi...	FPA008	18 Years -	Five Prime Therapeutics, Inc.
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan	NCT04703322	Tenosynovial Gi...	Pexidartinib	20 Years -	Daiichi Sankyo
A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT	NCT04488822	Tenosynovial Gi...	Pexidartinib	18 Years -	Daiichi Sankyo
A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment	NCT04635111	Hepatotoxicity Tenosynovial Gi...	TURALIO™	18 Years -	Daiichi Sankyo
A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor	NCT02673736	Solid Tumors Tenosynovial Gi... Synovitis, Pigm...	PLX73086	18 Years -	Plexxikon
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan	NCT04703322	Tenosynovial Gi...	Pexidartinib	20 Years -	Daiichi Sankyo
A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT	NCT04488822	Tenosynovial Gi...	Pexidartinib	18 Years -	Daiichi Sankyo
Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor	NCT01207492	Pigmented Villo... Diffuse-type Gi... Tenosynovial Gi...	nilotinib	18 Years -	Dana-Farber Cancer Institute
A Phase 2 Study of Intravenous AMB-05X in Tenosynovial Giant Cell Tumor Patients	NCT04938180	Tenosynovial Gi... Pigmented Villo... TGCT PVNS - Pigmente...	AMB-05X	18 Years -	AmMax Bio, Inc.
Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib	NCT04526704	Tenosynovial Gi...	Pexidartinib	18 Years -	Daiichi Sankyo
Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor	NCT01207492	Pigmented Villo... Diffuse-type Gi... Tenosynovial Gi...	nilotinib	18 Years -	Dana-Farber Cancer Institute
Study of Vimseltinib for Tenosynovial Giant Cell Tumor	NCT05059262	Tenosynovial Gi... Pigmented Villo... Giant Cell Tumo... Tenosynovial Gi... Tenosynovial Gi...	vimseltinib Placebo	18 Years -	Deciphera Pharmaceuticals LLC
An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee	NCT04731675	Tenosynovial Gi... Pigmented Villo...	AMB-05X	18 Years -	AmMax Bio, Inc.
A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan	NCT04703322	Tenosynovial Gi...	Pexidartinib	20 Years -	Daiichi Sankyo
Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib	NCT04526704	Tenosynovial Gi...	Pexidartinib	18 Years -	Daiichi Sankyo
A Study of the Efficacy and Safety of Pexidartinib in Adult Subjects With TGCT	NCT04488822	Tenosynovial Gi...	Pexidartinib	18 Years -	Daiichi Sankyo
A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor	NCT02673736	Solid Tumors Tenosynovial Gi... Synovitis, Pigm...	PLX73086	18 Years -	Plexxikon
An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee	NCT04731675	Tenosynovial Gi... Pigmented Villo...	AMB-05X	18 Years -	AmMax Bio, Inc.
Study of Cabiralizumab in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor	NCT02471716	Pigmented Villo... Tenosynovial Gi...	FPA008	18 Years -	Five Prime Therapeutics, Inc.
Phase 1 Study of PLX7486 as Single Agent in Patients With Advanced Solid Tumors	NCT01804530	Solid Tumor Tumors of Any H... Tenosynovial Gi...	PLX7486 TsOH	18 Years -	Plexxikon
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor	NCT04192344	Neoplasms Tenosynovial Gi...	ABSK021	18 Years -	Abbisko Therapeutics Co, Ltd
Phase 3 Study of Pexidartinib for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)	NCT02371369	Pigmented Villo... Giant Cell Tumo... Tenosynovial Gi...	Pexidartinib Placebo	18 Years -	Daiichi Sankyo
Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib	NCT04526704	Tenosynovial Gi...	Pexidartinib	18 Years -	Daiichi Sankyo
Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)	NCT05804045	Tenosynovial Gi... Pigmented Villo... Giant Cell Tumo...	Pimicotinib(ABS... Placebo	18 Years -	Abbisko Therapeutics Co, Ltd
Study to Evaluate Discontinuation and Re-Treatment in Participants With Tenosynovial Giant Cell Tumor (TGCT) Previously Treated With Pexidartinib	NCT04526704	Tenosynovial Gi...	Pexidartinib	18 Years -	Daiichi Sankyo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: